Reduction of abdominal obesity through lifestyle measures can improve all components of the metabolic syndrome
and likely delay the development of both diabetes and atherosclerosis. Beyond lifestyle intervention, optimal
management of risk factors to evidence-based targets is essential. High awareness of health problems caused due to
change in lifestyle and optimal management of risk factors can improve the metabolic syndrome and likely reduce the
development of both diabetes and atherosclerosis and hence reducing the demand for the atherectomy devices. The
major companies of the Atherectomy Devices Market include Bayer AG, Cardiovascular systems, St. Jude medica,
Boston scientific corporation, Abbott laboratories, C.R Bard Inc., Volcano Corporation. The competition in this
Atherectomy Devices Market usually depends on the technology used in manufacturing of the devices and also the
pricing strategies. Medtronic’s is leading competitor in peripheral atherectomy devices. Medtronic acquired Covedian
in 2015 and is expected to remain in the leading position however it will face increasing competition from
cardiovascular systems Inc.
Market Segment:
This report studies Atherectomy Devices in Global market, especially in North America, Europe, China, Japan,
Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and
market share for each manufacturer, covering
• Boston Scientific
• Cardiovascular Systems
• Medtronic
• Spectranetics
• Other prominent vendors
• Avinger
• Volcano
See More Reports of This Category by Million Insights @
https://www.millioninsights.com/industry/medical-devices
Market Segment by Regions, this report splits Global into several key Region, with production, consumption,
revenue, market share and growth rate of Atherectomy Devices in these regions, from 2011 to 2021 (forecast), like
• North America
• China